Why the study?
The precise role of calcineurin in regulating the transient outward potassium current (I to), an ion channel linked to fatal arrhythmia in hypertrophic cardiomyocytes, remains controversial.
Does Calcineurin Aβ (CnAβ) gene knockdown inhibit transient outward potassium current (Ito) channel remodeling and action potential duration (APD) prolongation in hypertrophic neonatal rat ventricular myocytes?
Does Calcineurin Aβ (CnAβ) gene knockdown inhibit transient outward potassium current (Ito) channel remodeling and action potential duration (APD) prolongation in hypertrophic neonatal rat ventricular myocytes?
CnAβ gene knockdown inhibits Ito channel remodeling and APD prolongation in hypertrophic neonatal rat ventricular myocytes, suggesting calcineurin as a potential target for preventing malignant ventricular arrhythmias in cardiac hypertrophy.
Attenuates Ito remodeling in hypertrophic neonatal myocytes; leaves open calcineurin as arrhythmia target pending larger studies.
It has been shown that the activation of calcineurin is involved in regulating ion channel remodeling in hypertrophic cardiomyocytes. But the precise role of calcineurin in the regulation of transient outward potassium current ( I to ), an ion channel associated with fatal arrhythmia, remains controversial. This study aimed to examine the effects of calcineurin Aβ ( CnAβ ) gene knockdown on I to channel remodeling and action potential duration (APD) in the hypertrophic ventricular myocytes of neonatal rats. Results showed that phenylephrine stimulation caused hypertrophy of ventricular myocytes, upregulation of CnAβ protein expression, downregulation of Kv4.2 mRNA and protein expression, a decrease in I to current density, and prolongation of APD. CnAβ gene knockdown significantly inhibited the effects of phenylephrine stimulation. Our data indicate that CnAβ gene knockdown can inhibit I to channel remodeling and APD prolongation in hypertrophic neonatal rat ventricular myocytes. This finding suggests that calcineurin may be a potential target for the prevention of malignant ventricular arrhythmia in a hypertrophic heart.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: